治疗药物-话题@MedSci

#治疗药物#

300篇内容 | 2630人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1921764, encodeId=c79a1921e64c5, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=脊髓性肌萎缩症治疗药物诺西那生钠注射液在全国开启患者治疗, objectType=article, longId=180942, objectId=0f31180942c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f31180942c2, replyNumber=0, likeNumber=58, createdTime=2019-10-16, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f31180942c2, moduleTitle=脊髓性肌萎缩症治疗药物诺西那生钠注射液在全国开启患者治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f31180942c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921728, encodeId=652e1921e2878, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=2张表概括糖尿病痛性神经病变治疗药物, objectType=article, longId=156226, objectId=1921156226a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1921156226a5, replyNumber=0, likeNumber=111, createdTime=2019-05-04, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1921156226a5, moduleTitle=2张表概括糖尿病痛性神经病变治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1921156226a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921756, encodeId=087f1921e56d7, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=急性髓细胞白血病的治疗药物或将再添新成员：MB-102（CD123 CAR T）获FDA孤儿药物认定, objectType=article, longId=176182, objectId=3d741e61824e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d741e61824e, replyNumber=0, likeNumber=74, createdTime=2020-05-12, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d741e61824e, moduleTitle=急性髓细胞白血病的治疗药物或将再添新成员：MB-102（CD123 CAR T）获FDA孤儿药物认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d741e61824e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921730, encodeId=b1b61921e3048, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=Inflam Bowel Dis：炎症性肠病患者从单抗治疗药物转换为生物仿制药CT-P13后的药物存活和免疫原性, objectType=article, longId=157182, objectId=d67915e182c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d67915e182c6, replyNumber=0, likeNumber=70, createdTime=2019-02-07, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d67915e182c6, moduleTitle=Inflam Bowel Dis：炎症性肠病患者从单抗治疗药物转换为生物仿制药CT-P13后的药物存活和免疫原性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d67915e182c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921732, encodeId=a6891921e322d, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=Orkambi：欧盟批准的2-5岁儿童囊性纤维化治疗药物, objectType=article, longId=158981, objectId=4d1c1589815f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d1c1589815f, replyNumber=0, likeNumber=85, createdTime=2019-04-30, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d1c1589815f, moduleTitle=Orkambi：欧盟批准的2-5岁儿童囊性纤维化治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d1c1589815f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921743, encodeId=3ffd1921e43f5, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=诺华的脊髓性肌萎缩症基因治疗药物Zolgensma，临床试验中出现第二次死亡事件, objectType=article, longId=164833, objectId=2160164833a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2160164833a3, replyNumber=0, likeNumber=72, createdTime=2020-03-01, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2160164833a3, moduleTitle=诺华的脊髓性肌萎缩症基因治疗药物Zolgensma，临床试验中出现第二次死亡事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2160164833a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921736, encodeId=42dc1921e3612, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=诺华公司获得授权Akcea的新型心血管治疗药物, objectType=article, longId=161113, objectId=0e0d16111313, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e0d16111313, replyNumber=0, likeNumber=74, createdTime=2020-02-08, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e0d16111313, moduleTitle=诺华公司获得授权Akcea的新型心血管治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e0d16111313)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921757, encodeId=ef961921e57b7, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=辉瑞宣布镰状细胞病治疗药物rivipansel的后期研究未达到关键目标, objectType=article, longId=176953, objectId=30fd1e69539b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30fd1e69539b, replyNumber=0, likeNumber=73, createdTime=2020-05-06, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30fd1e69539b, moduleTitle=辉瑞宣布镰状细胞病治疗药物rivipansel的后期研究未达到关键目标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30fd1e69539b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921759, encodeId=f4811921e59f8, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=掌中“包”别大意！腱鞘巨细胞瘤迎来最佳治疗药物Turalio, objectType=article, longId=177256, objectId=df4e1e72566a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df4e1e72566a, replyNumber=0, likeNumber=75, createdTime=2020-02-20, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df4e1e72566a, moduleTitle=掌中“包”别大意！腱鞘巨细胞瘤迎来最佳治疗药物Turalio, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df4e1e72566a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921724, encodeId=ab111921e247d, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=NMPA：急性缺血性脑卒中治疗药物临床试验技术指导原则（2018年第28号）, objectType=article, longId=152965, objectId=ccd61529657a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccd61529657a, replyNumber=0, likeNumber=66, createdTime=2019-03-05, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccd61529657a, moduleTitle=NMPA：急性缺血性脑卒中治疗药物临床试验技术指导原则（2018年第28号）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ccd61529657a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921752, encodeId=b35d1921e52bf, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=礼来的CGRP抑制剂Emgality喜获FDA批准，成为阵发性丛集性头痛的治疗药物, objectType=article, longId=167749, objectId=2b1416e7498d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b1416e7498d, replyNumber=0, likeNumber=66, createdTime=2020-02-24, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b1416e7498d, moduleTitle=礼来的CGRP抑制剂Emgality喜获FDA批准，成为阵发性丛集性头痛的治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b1416e7498d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921725, encodeId=73f91921e250b, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=NMPA：慢性乙型肝炎抗病毒治疗药物临床试验技术指导原则（2018年第29号）, objectType=article, longId=152966, objectId=6bf3152966e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bf3152966e3, replyNumber=0, likeNumber=71, createdTime=2019-05-03, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bf3152966e3, moduleTitle=NMPA：慢性乙型肝炎抗病毒治疗药物临床试验技术指导原则（2018年第29号）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bf3152966e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921750, encodeId=18171921e505f, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=骨巨细胞瘤治疗药物安加维®地舒单抗在中国获批, objectType=article, longId=166995, objectId=d68d1669952c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d68d1669952c, replyNumber=0, likeNumber=17, createdTime=2020-04-20, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d68d1669952c, moduleTitle=骨巨细胞瘤治疗药物安加维®地舒单抗在中国获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d68d1669952c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921751, encodeId=32461921e513e, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=银屑病治疗药物本维莫德乳膏获批上市, objectType=article, longId=167402, objectId=130e16e402bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=130e16e402bf, replyNumber=0, likeNumber=89, createdTime=2019-10-11, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=130e16e402bf, moduleTitle=银屑病治疗药物本维莫德乳膏获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=130e16e402bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921735, encodeId=7eb81921e358c, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=由于定价过高，英国NICE拒绝了BioMarin的Batten疾病治疗药物, objectType=article, longId=160827, objectId=25b316082e05, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25b316082e05, replyNumber=0, likeNumber=79, createdTime=2019-11-10, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25b316082e05, moduleTitle=由于定价过高，英国NICE拒绝了BioMarin的Batten疾病治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25b316082e05)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921731, encodeId=59f41921e3186, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=JAMA：疾病延缓治疗药物与继发性多发性硬化转化, objectType=article, longId=158196, objectId=0c021581968a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c021581968a, replyNumber=0, likeNumber=75, createdTime=2019-10-24, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c021581968a, moduleTitle=JAMA：疾病延缓治疗药物与继发性多发性硬化转化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c021581968a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921739, encodeId=b2eb1921e39f7, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=研究人员发现治疗药物性肝损伤的新靶标：血小板反应蛋白-1, objectType=article, longId=163895, objectId=0bde1638956a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bde1638956a, replyNumber=0, likeNumber=77, createdTime=2019-09-29, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bde1638956a, moduleTitle=研究人员发现治疗药物性肝损伤的新靶标：血小板反应蛋白-1, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bde1638956a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921749, encodeId=7a8d1921e4986, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=骨巨细胞瘤治疗药物安加维®地舒单抗在中国获批, objectType=article, longId=166994, objectId=0e3516699448, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e3516699448, replyNumber=0, likeNumber=70, createdTime=2020-04-20, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e3516699448, moduleTitle=骨巨细胞瘤治疗药物安加维®地舒单抗在中国获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e3516699448)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921729, encodeId=7fda1921e29ff, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=中国炎症性肠病治疗药物监测专家共识意见, objectType=article, longId=156496, objectId=20e215649643, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20e215649643, replyNumber=0, likeNumber=25, createdTime=2019-03-18, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20e215649643, moduleTitle=中国炎症性肠病治疗药物监测专家共识意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20e215649643)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1921717, encodeId=7ab01921e173d, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, objectTitle=Virus Res：奎宁可作为抗登革热病毒感染治疗药物, objectType=article, longId=146085, objectId=81451460856a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81451460856a, replyNumber=0, likeNumber=65, createdTime=2018-12-18, rootId=0, userName=周虎, userId=c9d3459, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81451460856a, moduleTitle=Virus Res：奎宁可作为抗登革热病毒感染治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81451460856a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

治疗药物

2020-05-29

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

脊髓性肌萎缩症治疗药物诺西那生钠注射液在全国开启患者治疗

2019-10-16

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

2张表概括糖尿病痛性神经病变治疗药物

2019-05-04

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

急性髓细胞白血病的治疗药物或将再添新成员：MB-102（CD123 CAR T）获FDA孤儿药物认定

2020-05-12

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

Inflam Bowel Dis：炎症性肠病患者从单抗治疗药物转换为生物仿制药CT-P13后的药物存活和免疫原性

2019-02-07

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

Orkambi：欧盟批准的2-5岁儿童囊性纤维化治疗药物

2019-04-30

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

诺华的脊髓性肌萎缩症基因治疗药物Zolgensma，临床试验中出现第二次死亡事件

2020-03-01

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

诺华公司获得授权Akcea的新型心血管治疗药物

2020-02-08

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

辉瑞宣布镰状细胞病治疗药物rivipansel的后期研究未达到关键目标

2020-05-06

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

掌中“包”别大意！腱鞘巨细胞瘤迎来最佳治疗药物Turalio

2020-02-20

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

NMPA：急性缺血性脑卒中治疗药物临床试验技术指导原则（2018年第28号）

2019-03-05

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

礼来的CGRP抑制剂Emgality喜获FDA批准，成为阵发性丛集性头痛的治疗药物

2020-02-24

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

NMPA：慢性乙型肝炎抗病毒治疗药物临床试验技术指导原则（2018年第29号）

2019-05-03

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

骨巨细胞瘤治疗药物安加维®地舒单抗在中国获批

2020-04-20

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

银屑病治疗药物本维莫德乳膏获批上市

2019-10-11

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

由于定价过高，英国NICE拒绝了BioMarin的Batten疾病治疗药物

2019-11-10

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

JAMA：疾病延缓治疗药物与继发性多发性硬化转化

2019-10-24

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

研究人员发现治疗药物性肝损伤的新靶标：血小板反应蛋白-1

2019-09-29

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

骨巨细胞瘤治疗药物安加维®地舒单抗在中国获批

2020-04-20

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

中国炎症性肠病治疗药物监测专家共识意见

2019-03-18

周虎 (审核中...)

前往app查看评论内容

#治疗药物#

Virus Res：奎宁可作为抗登革热病毒感染治疗药物

2018-12-18

科室
- - 订阅+
  - 更多科室
工具
服务